Home

A study which tracked almost 10,000 women with BRCA1 or BRCA2 gene mutations for up to 20 years has provided the clearest picture yet of the long-term breast and ovarian cancer risks for women who have inherited an abnormality in these cancer-risk genes.

Research led by Peter Mac has found a way to map, in unprecedented detail, all of a drug’s clinically important interactions in the body.The new tools can reveal how a small-molecule drug works at the cellular or genetic level, providing scientists with powerful new insights into what drives or -...

Australian researchers have found a new way to use immunotherapy, a breakthrough mode of cancer treatment which harnesses the patient’s immune system, to treat an aggressive form of breast cancer.The researchers at Peter MacCallum Cancer Centre and Walter and Eliza Hall Institute have shown, for...